Has psychopharmacology got a future? (49/83)

 (+info)

Epigenetic treatments for cognitive impairments. (50/83)

 (+info)

Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. (51/83)

 (+info)

Review of pharmacological treatment in mood disorders and future directions for drug development. (52/83)

 (+info)

Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. (53/83)

 (+info)

New medications for substance use disorders: challenges and opportunities. (54/83)

 (+info)

Current status and future prospects for epigenetic psychopharmacology. (55/83)

 (+info)

Psychopharmacological enhancement: a conceptual framework. (56/83)

 (+info)